149 related articles for article (PubMed ID: 34595942)
1. Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
Szeto SK; Mohamed S; Tsang CW; Chan CK
Eur J Ophthalmol; 2023 Jan; 33(1):NP55-NP63. PubMed ID: 34595942
[TBL] [Abstract][Full Text] [Related]
2. Leukostasis retinopathy with leukemic infiltrates as onset manifestation of chronic myeloid leukemia: a case report.
Vicini G; Nicolosi C; Malandrino D; Tozzetti C; Rizzo S; Sodi A
Eur J Ophthalmol; 2021 Sep; 31(5):NP116-NP121. PubMed ID: 32476461
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates.
Goel N; Pangtey B; Thakar M; Raina UK; Ghosh B
J AAPOS; 2012 Aug; 16(4):406-8. PubMed ID: 22929456
[TBL] [Abstract][Full Text] [Related]
4. RETINAL INFILTRATION IN A CASE OF CHRONIC MYELOID LEUKEMIA.
Yee C; Scruggs BA; Flaxel CJ
Retin Cases Brief Rep; 2023 Nov; 17(6):690-693. PubMed ID: 35385433
[TBL] [Abstract][Full Text] [Related]
5. Leukemic retinopathy and foveal infiltrates.
Kumar V; Kumawat D; Dhakal S
Int Ophthalmol; 2018 Jun; 38(3):1301-1303. PubMed ID: 28527028
[TBL] [Abstract][Full Text] [Related]
6. [Sudden bilateral decreased vision in a 14-year-old boy].
Marx S; Scheuerle A; Khoramnia R; Tandogan T; Kaiser D; Auffarth GU; Sel S
Ophthalmologe; 2017 Aug; 114(8):748-750. PubMed ID: 28138752
[No Abstract] [Full Text] [Related]
7. Unilateral Subhyaloid Hemorrhage as a Presenting Sign of Chronic Myeloid Leukemia.
Almater AI; Alhadlaq GS; Alromaih AZ
Am J Case Rep; 2022 Apr; 23():e936266. PubMed ID: 35484832
[TBL] [Abstract][Full Text] [Related]
8. Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia.
Christoforidis JB; DeAngelo DJ; D'Amico DJ
Am J Ophthalmol; 2003 Mar; 135(3):398-400. PubMed ID: 12614767
[TBL] [Abstract][Full Text] [Related]
9. Bilateral Central Retinal Vein Occlusion as Presenting Feature of Chronic Myeloid Leukemia.
Narang S; Gupta P; Sharma A; Sood S; Palta A; Goyal S
Middle East Afr J Ophthalmol; 2016; 23(3):253-5. PubMed ID: 27555710
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.
Cornea MI; Levrat E; Pugin P; Betticher DC
J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients.
Hailemariam TS; Mehdi M; Kinde S; Seifu D; Edao A
Recent Pat Anticancer Drug Discov; 2021; 16(3):445-455. PubMed ID: 33618649
[TBL] [Abstract][Full Text] [Related]
12. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.
Wolff NC; Veach DR; Tong WP; Bornmann WG; Clarkson B; Ilaria RL
Blood; 2005 May; 105(10):3995-4003. PubMed ID: 15657179
[TBL] [Abstract][Full Text] [Related]
13. Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.
Lernoux M; Schnekenburger M; Losson H; Vermeulen K; Hahn H; Gérard D; Lee JY; Mazumder A; Ahamed M; Christov C; Kim DW; Dicato M; Bormans G; Han BW; Diederich M
Clin Epigenetics; 2020 May; 12(1):69. PubMed ID: 32430012
[TBL] [Abstract][Full Text] [Related]
14. Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature.
Chen B; Yan X; Zhang X; Yang H
Indian J Ophthalmol; 2018 Dec; 66(12):1871-1874. PubMed ID: 30451209
[TBL] [Abstract][Full Text] [Related]
15. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.
Sazawal S; Chikkara S; Singh K; Chaubey R; Chandra D; Mishra P; Mahapatra M; Seth T; Saxena R
Ann Diagn Pathol; 2017 Apr; 27():24-27. PubMed ID: 28325357
[TBL] [Abstract][Full Text] [Related]
16. ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUS.
Al Falah M; Ballios BG; Yeung SC; Mehraban Far P; Yan P
Retin Cases Brief Rep; 2023 Jan; 17(1):61-64. PubMed ID: 33252507
[TBL] [Abstract][Full Text] [Related]
17. Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.
Hardling M; Wei Y; Palmqvist L; Swolin B; Stockelberg D; Gustavsson B; Ekeland-Sjöberg K; Wadenvik H; Ricksten A
Med Oncol; 2004; 21(4):349-58. PubMed ID: 15579919
[TBL] [Abstract][Full Text] [Related]
18. Priapism as a result of chronic myeloid leukemia: case report, pathology, and review of the literature.
Shaeer OK; Shaeer KZ; AbdelRahman IF; El-Haddad MS; Selim OM
J Sex Med; 2015 Mar; 12(3):827-34. PubMed ID: 25630365
[TBL] [Abstract][Full Text] [Related]
19. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring.
Jabbour E; Kantarjian H
Am J Hematol; 2022 Sep; 97(9):1236-1256. PubMed ID: 35751859
[TBL] [Abstract][Full Text] [Related]
20. [Imatinib is effective in a 12-month-old boy with chronic myelogenous leukemia: case report and literature review].
Pan Y; Wen S; Tian J; Lyu Z; Du Z; Yan L
Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):194-7. PubMed ID: 26165016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
